Kepos Capital LP Arrowhead Pharmaceuticals, Inc. Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $1.09 Million - $2.84 Million	-38,848 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$26.26 - $34.86 $713,746 - $947,494	27,180 Added 232.94%	38,848 $1.1 Million
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $203,373 - $336,271	11,668 New	11,668 $309,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.